
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Brosimum alicastrum nut contains polyphenols that activate PPAR-α and AMPK pathways to regulate hepatic lipid metabolism and enhance β-oxidation. These bioactive compounds also activate NRF2 antioxidant response pathways while providing complete plant-based protein and essential minerals.

Reported Benefits (Provisional)
Origin & History

The Brosimum Nut is the seed of Brosimum alicastrum, commonly known as the breadnut tree, native to the tropical regions of Central America, Mexico, and the Caribbean islands. Thriving in diverse forest environments, this nutrient-dense nut is a complete plant-based protein source, offering profound benefits for sustained energy and overall vitality.
Research Narrative (Provisional)
Nutritional and ethnobotanical research consistently supports the Brosimum Nut's status as a high-protein, antioxidant-rich food source. Studies validate its significant role in traditional food systems and highlight its potential in addressing malnutrition and enhancing food security.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Macronutrients: High-quality Protein (full spectrum of essential amino acids), Complex Carbohydrates (for sustained energy), Dietary Fiber. - Vitamins: Vitamins A, B1 (Thiamine), B2 (Riboflavin), B3 (Niacin), C, E (for immunity, metabolism, skin health). - Minerals: Calcium, Potassium, Iron (for bone health, electrolyte balance, oxygen transport). - Phytochemicals: Flavonoids, Polyphenols (for antioxidant effects).
Reported Mechanism (Provisional)
Polyphenols in Brosimum nuts activate peroxisome proliferator-activated receptor alpha (PPAR-α), regulating gene expression of β-oxidation enzymes and preventing hepatic lipid accumulation. AMPK phosphorylation at Thr172 decreases malonyl-CoA levels and activates CPT1, enhancing mitochondrial fatty acid transport. NRF2 pathway activation increases antioxidant gene expression while neutralizing reactive oxygen species through direct electron donation.
Clinical Narrative (Provisional)
Research consists primarily of animal and in vitro studies with limited human clinical data available. Gene expression studies demonstrated increased Acox1 and Cpt1 gene expression and AMPK phosphorylation in animal models. Antioxidant capacity measurements showed ABTS values of 68.18-72.89 μM TEAC/g and FRAP values of 7.032-29.84 μM TEAC/g in laboratory assays. Human clinical trials with specific dosages and outcomes are needed to validate therapeutic effects.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







